StockNews.com downgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) from a buy rating to a hold rating in a report issued on Saturday. Separately, TheStreet cut shares of Vanda Pharmaceuticals from a c- rating to a d rating in a research note on Thursday, February 8th. Read Our Latest Report on Vanda Pharmaceuticals Vanda […]
StockNews.com upgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) from a hold rating to a buy rating in a report issued on Thursday. Vanda Pharmaceuticals Stock Performance Vanda Pharmaceuticals stock opened at $3.76 on Thursday. The firm has a market cap of $216.31 million, a price-to-earnings ratio of 17.91 and a beta of 0.59. […]
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totalling 1,510,000 shares, a decline of 64.1% from the September 15th total of 4,210,000 shares. Currently, 3.1% of the company’s stock are short sold. Based on an […]
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Short Interest Update kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) SVP Timothy Williams sold 14,600 shares of the firm’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $6.56, for a total value of $95,776.00. Following the transaction, the senior vice president now owns 88,913 shares in the company, valued […]